Strategic Partners
642.00 DKK
+15.47 %
Less than 1K followers
STRAP
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Strategic Partners
P/E
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2024
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Share price (DKK) | 72,400.00 | 67,100.00 | 17,160.00 | 880.00 | 1,330.00 | 825.10 |
| Shares | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Market cap | 1,442.8 | 1,903.4 | 599.8 | 31.1 | 47.0 | 34.4 |
| Enterprise value | 1,393.4 | 1,243.5 | 537.5 | -11.4 | 35.7 | 30.5 |
| EV/S | - | - | 14.9 | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | 0.3 | neg. | neg. |
| EV/EBIT | neg. | neg. | neg. | 0.3 | neg. | neg. |
| P/E | neg. | neg. | neg. | 1.2 | neg. | neg. |
| P/B | 27.24 | 3.07 | 17.16 | 0.75 | 3.30 | 1.79 |
| P/S | - | - | 16.6 | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 29.3 % | 75.4 % | 20.2 % | 71.7 % | 73.7 % | 81.7 % |
| Gearing ratio | 140.1 % | 10.8 % | 114.4 % | - | - | - |